Group 1 - Quipt Home Medical Corp. (NASDAQ:QIPT) is identified as a fundamentally strong penny stock with recent investment interest from Nuveen LLC, which acquired 150,046 shares valued at approximately $350,000, representing nearly 0.35% ownership of the company [1] - The company is enhancing its growth through strategic partnerships, recently completing a venture transaction with three health systems and two hospitals [2] - Quipt's acquisition of Hart Medical Equipment for $17.4 million results in a 60% ownership interest, with the remaining shares held by several health systems, contributing to stabilized revenue and adjusted EBITDA while creating additional growth opportunities [3] Group 2 - Quipt Home Medical Corp. is based in Kentucky and specializes in providing durable and home medical equipment, focusing on high-quality home care solutions such as nebulizers and invasive ventilation [4]

Core Insights - The article discusses fundamentally strong penny stocks that present investment opportunities, emphasizing the combination of high value and low price as a key factor for potential gains [1][2]. Group 1: Penny Stocks Overview - Penny stocks are defined as shares trading under $5, historically showing strong performance and offering opportunities for early investment in emerging companies [2]. - Investors must be discerning to differentiate between good and bad penny stock investments, with strategies that can yield abnormal profits over both short- and long-term periods [3]. Group 2: Methodology for Stock Selection - A list of 12 fundamentally strong penny stocks was compiled, focusing on those with over 5% EPS growth over the past 5 years and positive sales growth, ranked by upside potential based on one-year price targets from Yahoo Finance [5]. Group 3: Company Highlights - **Quipt Home Medical Corp. (NASDAQ:QIPT)**: - Has an upside potential of 31.39% as of September 19, 2025, with a recent acquisition of 150,046 shares by Nuveen LLC valued at approximately $350,000 [7][8]. - The company is expanding through strategic partnerships and a $17.4 million acquisition of Hart Medical Equipment, enhancing revenue stability and future growth opportunities [9][10][11]. - **MDxHealth SA (NASDAQ:MDXH)**: - Shows an upside potential of 45.99% as of September 19, 2025, following the acquisition of Bio-Techne Corporation's ExoDx business for $15 million, aimed at strengthening its precision diagnostics portfolio [12][13][14][15]. - **Butterfly Network, Inc. (NYSE:BFLY)**: - Exhibits an upside potential of 71.35% as of September 19, 2025, with a significant increase in institutional ownership and record quarterly revenue, alongside a bullish outlook from analysts [16][17][18][19].